LBF20210PG01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
| |
Revision as of 06:00, 7 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1729 |
| LipidMaps | LMFA03010033 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20210PG01 |
| 13,14-dihydro-15-keto Prostaglandin A2 | |
|---|---|
| |
| Structural Information | |
| 9-oxo-15R-hydroxy-prostsa-10,13E-dien-1-oic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C(CCC(=O)CC[C@H]([C@H]1CC=CCCCC(O)=O)C=CC(=O)1)CC |
| Physicochemical Information | |
| 13,14-dihydro-15-keto PGA2 is produced via non-enzymatic dehydration of 13,14-dihydro-15-keto PGE2, whose process is a ccelerated by the presence of albumin. Granstrom_E et al. Fitzpatrick_FA et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
